Corbus Pharmaceuticals: Q4 Earnings Snapshot
March 15, 2021
FacebookTwitterEmail
NORWOOD, Mass. (AP) Corbus Pharmaceuticals Holdings Inc. (CRBP) on Monday reported a loss of $8.6 million in its fourth quarter.
On a per-share basis, the Norwood, Massachusetts-based company said it had a loss of 10 cents.
The drug developer posted revenue of $658,200 in the period. Its adjusted revenue was $658,000, which missed Street forecasts. Four analysts surveyed by Zacks expected $1.2 million.
For the year, the company reported that its loss widened to $111.3 million, or $1.42 per share. Revenue was reported as $3.9 million.
The company s shares closed at $2.33. A year ago, they were trading at $4.07.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRBP at https://www.zacks.com/ap/CRBP
Earnings Scheduled For March 15, 2021 benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of entry has been complicated by the historic scheduling of cannabis as a schedule 1 narcotic. However, pharmaceutical cannabis products such as Epidyolex, Sativex and Dronabinol have become serious alternatives to traditional pharmaceuticals and are beginning to shift how the pharma industry approaches cannabis.
Clinical trials and academic studies are on the rise, constantly changing our understanding of the cannabis plant. In tandem, commercial opportunities are emerging as innovation, capital and technology create a space for a new form of cannabis-based medicines, which will change the way we medicate over the next 5-10 years. This report unpacks the regulatory landscape across key markets, analyses the key trends which are changing the face of the market and examines th
Top marijuana stocks to watch Top marijuana stocks to watch
Joshua Warner March 2, 2021 4:05 PM
Countries around the world have embraced marijuana by legalising its use for medicinal or recreational purposes. We explain what you need to know about the industry and have a look at the top cannabis stocks to watch. Share:
What you need to know about the marijuana market
The world has had a complicated relationship with marijuana. Many countries hardened their stance against the drug throughout the 1900s by banning the substance, but the attitude has softened since the turn of the century as more countries explore the potential health, social and commercial benefits of legalising and regulating the cannabis market.
Global Cannabis Pharmaceuticals Market Report 2020: Market is Expected to Reach $5 72 Billion by 2027 - Investments in R&D for Cannabis-Infused Drugs prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.